Bionomics Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
Bionomics Limited (BNOX)
Company Research
Source: GlobeNewswire
ADELAIDE, Australia, and CAMBRIDGE, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced that Spyridon “Spyros” Papapetropoulos M.D.., Ph.D., President and Chief Executive Officer of Bionomics, issued the following letter to Bionomics shareholders regarding recent achievements, executional efficiencies and the positive outlook for the Company’s future. Dear Fellow Bionomics Shareholders, This year continues to be a pivotal year for Bionomics, characterized by numerous wins and essential changes that have enhanced the Company and furthered our goal of creating therapies for the countless individuals suffering from anxiety and stress disorders. As we enter the last quarter of 2024, I would like to take a mome
Show less
Read more
Impact Snapshot
Event Time:
BNOX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNOX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNOX alerts
High impacting Bionomics Limited news events
Weekly update
A roundup of the hottest topics
BNOX
News
- Bionomics Limited (NASDAQ: BNOX) had its "outperform" rating re-affirmed by analysts at William Blair.MarketBeat
- Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement [Yahoo! Finance]Yahoo! Finance
- Bionomics Provides an Update on Re-domiciliation via Scheme of ArrangementGlobeNewswire
- Bionomics to Present at the 2024 CNS SummitGlobeNewswire
- Bionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology ProgramGlobeNewswire
BNOX
Sec Filings
- 11/21/24 - Form 8-K
- 11/18/24 - Form S-3
- 11/14/24 - Form 10-Q
- BNOX's page on the SEC website